Protocol[removed]RAC Presentation A P1 Ascending Dose Trial of the Safety and Tolerability of Toca 511, a Retroviral Replicating Vector, Administered to Subjects at the Time of Resection for rHGG and Followed by Treatm - Toca 511 - Document - PDFSEARCH.IO

First Page	Meta Content
	Protocol[removed]RAC Presentation A P1 Ascending Dose Trial of the Safety and Tolerability of Toca 511, a Retroviral Replicating Vector, Administered to Subjects at the Time of Resection for rHGG and Followed by Treatm Add to Reading List Document Date: 2013-12-31 11:55:11 Open Document File Size: 1,03 MB Share Result on Facebook Company Tocagen Inc. / / Currency pence / / MedicalCondition brain cancer / tumor / glioma cells / resected human glioma / intracranial tumors / / Organization MD VP / / Person Tai et al. Mol / Dan Pertschuk / / SocialTag Animal virology Retrovirus Vector Murine leukemia virus Brain tumor Toca 511 & Toca FC Biology Molecular biology Gene delivery

Protocol[removed]RAC Presentation A P1 Ascending Dose Trial of the Safety and Tolerability of Toca 511, a Retroviral Replicating Vector, Administered to Subjects at the Time of Resection for rHGG and Followed by TreatmAdd to Reading List